MedPath

Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:prospective study

Not Applicable
Conditions
Patients with ruptured gastric fundal varices
Registration Number
JPRN-UMIN000000784
Lead Sponsor
ational Hospital Organization Head quarter
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with advanced HCC who were unable to undergo curative treatment 2. Patients with a solitary HCC (more than 5cm in a diameter of the tumor) who received surgical treatment 3.Recurrent HCC 4.Portal vein thrombosis 5.Other malignancies without curative treatments 6.T.Bil > or =4mg/dl 7.Parmanent organ failure except for liver failure 8.Patients failed to hemostasis, or died within 24 hours from onset of bleeding 9. Patients received prior treatments of gastric varices (e.g., TIPS, surgery, PSE or splenectomy) 10.Patients whom judged to be inadequate by the doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cumulative rebleeding rates in patients with ruptured gastric fundal varices
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath